first commit
https://pubmed.ncbi.nlm.nih.gov/32135389/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718752/pdf/kjim-2018-460.pdf
https://www.nature.com/articles/nrd1564.pdf

Duloxetine Hydrochloride: A New Dual-Acting Medication for the Treatment of Major Depressive Disorder 
:The most commonly reported treatment-emergent
AEs associated with duloxetine in clinical trials were
nausea, dry mouth, fatigue, insomnia, dizziness, constipation, diarrhea, somnolence, decreased appetite,
and increased sweating 
最常见的治疗紧急情况
临床试验中与度洛西汀相关的不良事件为
恶心、口干、乏力、失眠、头晕、便秘、腹泻、嗜睡、食欲减退、
并且出汗增多
